News
The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...
Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...
Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...
1d
Clinical Trials Arena on MSNPEPFAR funding protection offers “hope” for people living with HIV"PEPFAR funding protection offers “hope” for people living with HIV" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
3h
NewsDay Zimbabwe on MSNZim reaffirms commitment to HIV responseHEALTH and Child Care minister Douglas Mombeshora has reaffirmed the country’s commitment to advancing HIV research, treatment and global collaboration. He said this during the ongoing 13th ...
The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with ...
22h
Medpage Today on MSNInvestigational Once-Weekly ART Combo Maintained Viral Suppression in HIVAn investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...
The World Health Organization (WHO) chief on Monday called on world leaders to prioritize HIV prevention and embrace ...
The International AIDS Society (IAS) on Sunday called on President Trump to increase funding for AIDS research, warning that his proposed spending cuts could cause deaths. IAS president Linda-Gail ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results